SphingoTec
ApprovedSphingoTec GmbH develops innovative biomarkers for diagnosis, prediction, and monitoring of acute medical conditions, such as acute kidney injury and sepsis.
Founded
2009
Focus
Diagnostics
About
SphingoTec GmbH develops innovative biomarkers for diagnosis, prediction, and monitoring of acute medical conditions, such as acute kidney injury and sepsis.
Funding History
2Total raised: $45M
Series B$30MBioMedPartnersSep 15, 2021
Series A$15MHigh-Tech GründerfondsMay 15, 2019
Company Info
TypePrivate
Founded2009
LocationHennigsdorf, Germany
StageApproved
Contact
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile